azelastine has been researched along with Rhinitis, Vasomotor in 5 studies
azelastine: azeptin is azelastine hydrochloride; structure; eye drop formulation effective in relieving symptoms of allergic conjunctivitis; do not confuse with 5-loxin which is an extract of Boswellia
azelastine : A phthalazine compound having an oxo substituent at the 1-position, a 1-methylazepan-4-yl group at the 2-position and a 4-chlorobenzyl substituent at the 4-position.
Rhinitis, Vasomotor: A form of non-allergic rhinitis that is characterized by nasal congestion and posterior pharyngeal drainage.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intranasal azelastine hydrochloride (Astelin, Meda Pharmaceuticals, Somerset, NJ, USA) is a first-line treatment for allergic and non-allergic vasomotor rhinitis with well-established therapeutic efficacy and safety." | 4.85 | Pharmacokinetic characteristics and safety and tolerability of a reformulated azelastine hydrochloride nasal spray in patients with chronic rhinitis. ( Berger, WE, 2009) |
| "Azelastine hydrochloride is an antihistamine with anti-inflammatory properties that is available in the United States in a nasal spray formulation for the treatment of seasonal allergic rhinitis." | 2.70 | Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. ( Banov, CH; Lieberman, P, 2001) |
| "Vasomotor rhinitis is a common disorder that is seen routinely in allergy practice." | 2.46 | Vasomotor rhinitis. ( Lieberman, P; Pattanaik, D, 2010) |
| "Although treatment of vasomotor rhinitis involves the use of either intranasal corticosteroids or antihistamines, the corticosteroids are generally not effective in treatment of all the symptoms of vasomotor rhinitis and have generally been shown to be effective in patients with eosinophilia." | 2.42 | Treatment of nonallergic perennial rhinitis. ( Ciprandi, G, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, U | 1 |
| Bernstein, JA | 1 |
| Lorentz, H | 1 |
| Sadoway, T | 1 |
| Nelson, V | 1 |
| Patel, P | 1 |
| Salapatek, AM | 1 |
| Berger, WE | 1 |
| Pattanaik, D | 1 |
| Lieberman, P | 2 |
| Ciprandi, G | 1 |
| Banov, CH | 1 |
3 reviews available for azelastine and Rhinitis, Vasomotor
| Article | Year |
|---|---|
Pharmacokinetic characteristics and safety and tolerability of a reformulated azelastine hydrochloride nasal spray in patients with chronic rhinitis.
Topics: Administration, Intranasal; Aerosols; Biological Availability; Clinical Trials as Topic; Histamine A | 2009 |
Vasomotor rhinitis.
Topics: Administration, Intranasal; Adrenal Cortex Hormones; Cholinergic Antagonists; Diagnosis, Differentia | 2010 |
Treatment of nonallergic perennial rhinitis.
Topics: Anti-Allergic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, | 2004 |
2 trials available for azelastine and Rhinitis, Vasomotor
| Article | Year |
|---|---|
A Pilot Study Investigating Clinical Responses and Biological Pathways of Azelastine/Fluticasone in Nonallergic Vasomotor Rhinitis before and after Cold Dry Air Provocation.
Topics: Adult; Air; Anti-Inflammatory Agents; Bronchial Provocation Tests; Cold Temperature; Cough; Female; | 2017 |
Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Child; Double-Blind Method; Female; Humans; Mal | 2001 |